ZYBERNO
Stock Report
Updated Aug 31, 2026

Lakeland Industries, Inc. (LAKE)

Healthcare • NASDAQ

$11.68

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
25.0/100
POOR BUSINESS
Lakeland Industries, Inc. (LAKE) scores 25/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-13.5%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.23x)
Operating Margin (Operational Efficiency):CRITICAL (-4.1%)
Return on Capital (Capital Efficiency):CRITICAL (-2.5%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

Lakeland Industries, Inc. (LAKE) stock report — Zyberno Score 25/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, LAKE generated -$10.65M in Owner Earnings. Capital was deployed as follows: $858.00K paid as dividends, $3.58M invested in capital expenditures. Reinvestment rate: -100.8%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:11.68
Market Cap:$115.19M

Valuation Multiples (3)

P/B Ratio:0.88x
P/S Ratio:0.59x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$145.59M

Price Action & Momentum (3)

Momentum Percentile:22 / 100
% of 52-Week High:64.9%
B. Profitability Assessment

Return Metrics (5)

ROA:-8.5%
Reinvestment Rate:-100.8%
Fundamental Growth Rate (g):2.5%

Margin Analysis (3)

Operating Margin Ttm:-4.1%
Net Margin Ttm:-9.6%
Ebitda Margin:-2.0%

TTM Performance (3)

Gross Margin Ttm:32.7%
Operating Margin Ttm:-4.1%
Net Margin Ttm:-9.6%

Yield Metrics (2)

Earnings Yield:-$16.23
Dividend Yield:0.7%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:112.3%
Latest Earnings Filed:2026-06-09

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):13.4%

Earnings Growth (Linear) (1)

Net Income Growth Rate (Linear):-21.5%

Cash Flow Growth (Linear) (2)

Free Cash Flow Growth Rate (Linear):2.9%
Operating Cash Flow Growth Rate (Linear):44.2%

Operating Growth (Linear) (1)

Operating Income Growth Rate (Linear):-7.2%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:3.09x
Quick Ratio:1.34x
Cash Ratio:0.00x

Leverage Analysis (3)

Debt To Equity Ttm:0.23x
Debt-to-Equity Ratio:0.23x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-7.24x
Times Interest Earned:-7.24

Capital Structure (4)

Working Capital:92,778,000.00
Cash And Cash Equivalents:0.00
Long Term Debt:$25.77M
Net Debt:$30.40M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $194.24M
Linear Growth: 13.4%
📊 Click to view full LAKE Revenue analysis & methodology →
Cost Of Revenue Ttm:$130.77M

Profitability Breakdown (2)

Gross profit TTM: $63.48M
Linear Growth: 8.3%
📊 Click to view full LAKE Gross Profit analysis & methodology →
Operating income TTM: -$8.01M
Linear Growth: -7.2%
📊 Click to view full LAKE Operating Income analysis & methodology →

Bottom Line Performance (3)

Net income TTM: -$18.73M
Linear Growth: -21.5%
📊 Click to view full LAKE Net Income analysis & methodology →
Income Before Tax:-$10.13M
Ebitda Ttm:-3,813,000.00

Operating Expenses (5)

Operating Expenses:78,712,000.00
R And D Expense:0.00
Sga Expense:0.00
Income Tax Expense:$8.60M
Interest Expense:2,144,000.00

Expense Ratios (3)

R And D To Revenue Percentage:0.0%
Sga To Revenue Percentage:0.0%
Ebitda Margin:-2.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$212.34M
Current Assets:$137.20M
Ppe Net:12,334,000.00
Goodwill:15,203,000.00
Intangible Assets:$30.93M

Liability Structure (4)

Total Liabilities:81,813,000.00
Current Liabilities:44,418,000.00
Long Term Debt:$25.77M
Short Term Debt:$4.63M

Equity & Capital (3)

Equity:$130.53M
Retained Earnings:$24.23M
Common Stock:20,000,000.00

Working Capital Items (3)

Accounts Receivable:31,461,000.00
Inventory:77,715,000.00
Accounts Payable:16,034,000.00

Special Items (2)

Contract Liabilities:6,574,000.00
Stock Based Compensation:800,000.00
C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: -$7.25M
Linear Growth: 44.2%
Free cash flow TTM: -$10.82M
Linear Growth: 2.9%
📊 Click to view full LAKE Free Cash Flow analysis & methodology →

Investment Activities (2)

Investing Cash Flow:$3.68M
Capital Expenditures Ttm:3,576,000.00

Financing Activities (3)

Financing Cash Flow:-$5.19M
Dividends Paid Ttm:858,000.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:4,197,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-1.93
Eps diluted TTM: -$1.93
Linear Growth: -34.3%
📊 Click to view full LAKE EPS analysis & methodology →
Earnings Per Share Ttm:-$1.90

Revenue & Cash Per Share (2)

Sales Per Share Ttm:19.70
Operating Cash Flow Per Share:-$1.60

Book Value & Capital (2)

Book Value Per Share:$13.23
Cash Per Share:-999.00

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.89x
Working Capital Turnover Ttm:2.09x

Receivables Management (2)

Receivables Turnover Ttm:6.17x
Days Sales Outstanding Ttm:59.12

Inventory Management (2)

Inventory Turnover Ttm:1.68x
Days Inventory Outstanding Ttm:216.92

Payables & Cash Cycle (2)

Days Payable Outstanding:44.76
Cash Conversion Cycle:231.29
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:40.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$10.65M

Damodaran Growth Analysis (2)

Reinvestment Rate:-100.8%
Fundamental Growth Rate (g):2.5%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (3)

Revenue Growth Rate (Linear):13.4%
Net Income Growth Rate (Linear):-21.5%
Operating Income Growth Rate (Linear):-7.2%

Cash Flow Growth Rates (2)

Free Cash Flow Growth Rate (Linear):2.9%
Operating Cash Flow Growth Rate (Linear):44.2%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):8.3%
Book Value Growth Rate (Linear):3.0%
C. Company Profile & Context

Corporate Information (6)

Symbol:LAKE
Company Name:Lakeland Industries, Inc.
Sector:Healthcare
Industry:Medical Devices
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:medium
Volume Category:N/A

Share Structure (3)

Shares Outstanding:9.86M
Shares Outstanding Basic:9.86M
Shares Outstanding Diluted:10.29M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-31 18:51:25 UTC
Data Timestamp:2026-08-19T18:31:26.826295
Scroll to Top